SCHEDULE 13G/A 0000908834-25-000241 0001814952 XXXXXXXX LIVE 2 Common Stock, $0.0001 par value per share (the "Shares") 09/30/2025 0001674632 Beta Bionics, Inc. 08659B102 11 Hughes Irvine CA 92618 Rule 13d-1(c) Zone Healthcare Holdings, LLC b DE 0 3277220 0 3277220 3277220 N 7.5 OO Farallon Capital Partners, L.P. b CA 0 185460 0 185460 185460 N 0.4 PN Farallon Capital Institutional Partners, L.P. b CA 0 199940 0 199940 199940 N 0.5 PN Farallon Capital Institutional Partners II, L.P. b CA 0 70718 0 70718 70718 N 0.2 PN Farallon Capital Institutional Partners III, L.P. b DE 0 47800 0 47800 47800 N 0.1 PN Four Crossings Institutional Partners V, L.P. b DE 0 46974 0 46974 46974 N 0.1 PN Farallon Capital Offshore Investors II, L.P. b E9 0 418307 0 418307 418307 N 1 PN Farallon Capital (AM) Investors, L.P. b DE 0 28860 0 28860 28860 N 0.1 PN Farallon Capital F5 Master I, L.P. b E9 0 38641 0 38641 38641 N 0.1 PN Farallon Capital Management, L.L.C. b DE 0 3277220 0 3277220 3277220 N 7.5 OO Farallon Partners, L.L.C. b DE 0 998059 0 998059 998059 N 2.3 OO Farallon F5 (GP), L.L.C. b DE 0 38641 0 38641 38641 N 0.1 OO Farallon Institutional (GP) V, L.L.C. b DE 0 46974 0 46974 46974 N 0.1 OO Dapice Joshua J. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Dreyfuss, Philip D. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Dunn Hannah E. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Fried, Richard B b X1 0 4313920 0 4313920 4313920 N 9.9 IN Gehani, Varun N. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Giauque, Nicolas b I0 0 4313920 0 4313920 4313920 N 9.9 IN Kim, David T. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Linn, Michael G. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Luo Patrick (Cheng) b F4 0 4313920 0 4313920 4313920 N 9.9 IN Patel, Rajiv A. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Roberts, Jr., Thomas G. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Saito Edric C. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Seybold, William b X1 0 4313920 0 4313920 4313920 N 9.9 IN Short Daniel S. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Spokes, Andrew J. M. b X0 0 4313920 0 4313920 4313920 N 9.9 IN Warren, John R. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Wehrly, Mark C. b X1 0 4313920 0 4313920 4313920 N 9.9 IN Beta Bionics, Inc. 11 Hughes, Irvine, California, 92618 This statement is filed by the entities and persons listed below, all of whom together are referred to herein as the "Reporting Persons." (i) Zone Healthcare Holdings, LLC, a Delaware limited liability company ("ZHH LLC"), with respect to the Shares held by it; (ii) Farallon Capital Partners, L.P., a California limited partnership ("FCP"), with respect to the Shares held by it; (iii) Farallon Capital Institutional Partners, L.P., a California limited partnership ("FCIP"), with respect to the Shares held by it; (iv) Farallon Capital Institutional Partners II, L.P., a California limited partnership ("FCIP II"), with respect to the Shares held by it; (v) Farallon Capital Institutional Partners III, L.P., a Delaware limited partnership ("FCIP III"), with respect to the Shares held by it; (vi) Four Crossings Institutional Partners V, L.P., a Delaware limited partnership ("FCIP V"), with respect to the Shares held by it; (vii) Farallon Capital Offshore Investors II, L.P., a Cayman Islands exempted limited partnership ("FCOI II"), with respect to the Shares held by it; (viii) Farallon Capital (AM) Investors, L.P., a Delaware limited partnership ("FCAMI"), with respect to the Shares held by it; and (ix) Farallon Capital F5 Master I, L.P., a Cayman Islands exempted limited partnership ("F5MI"), with respect to the Shares held by it. FCP, FCIP, FCIP II, FCIP III, FCIP V, FCOI II, FCAMI and F5MI are together referred to herein as the "Farallon Funds." (x) Farallon Capital Management, L.L.C., a Delaware limited liability company (the "Management Company"), which is the manager of ZHH LLC, with respect to the Shares held by ZHH LLC. (xi) Farallon Partners, L.L.C., a Delaware limited liability company (the "Farallon General Partner"), which is (i) the general partner of each of FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI, and (ii) the sole member of the FCIP V General Partner (as defined below), with respect to the Shares held by each of the Farallon Funds other than F5MI. (xii) Farallon Institutional (GP) V, L.L.C., a Delaware limited liability company (the "FCIP V General Partner"), which is the general partner of FCIP V, with respect to the Shares held by FCIP V. (xiii) Farallon F5 (GP), L.L.C., a Delaware limited liability company (the "F5MI General Partner"), which is the general partner of F5MI, with respect to the Shares held by F5MI. (xiv) The following persons, each of whom is a managing member or senior managing member, as the case may be, of the Management Company and the Farallon General Partner and a manager or senior manager, as the case may be, of the FCIP V General Partner and the F5MI General Partner, with respect to the Shares held by ZHH LLC and the Farallon Funds: Joshua J. Dapice ("Dapice"); Philip D. Dreyfuss ("Dreyfuss"); Hannah E. Dunn ("Dunn"); Richard B. Fried ("Fried"); Varun N. Gehani ("Gehani"); Nicolas Giauque ("Giauque"); David T. Kim ("Kim"); Michael G. Linn ("Linn"); Patrick (Cheng) Luo ("Luo"); Rajiv A. Patel ("Patel"); Thomas G. Roberts, Jr. ("Roberts"); Edric C. Saito ("Saito"); William Seybold ("Seybold"); Daniel S. Short ("Short"); Andrew J. M. Spokes ("Spokes"); John R. Warren ("Warren"); and Mark C. Wehrly ("Wehrly"). Dapice, Dreyfuss, Dunn, Fried, Gehani, Giauque, Kim, Linn, Luo, Patel, Roberts, Saito, Seybold, Short, Spokes, Warren and Wehrly are together referred to herein as the "Farallon Individual Reporting Persons." The address of the principal business office of each of the Reporting Persons is c/o Farallon Capital Management, L.L.C., One Maritime Plaza, Suite 2100, San Francisco, California 94111. The citizenship of each of ZHH LLC, the Farallon Funds, the Management Company, the Farallon General Partner, the FCIP V General Partner and the F5MI General Partner is set forth above. Each of the Farallon Individual Reporting Persons, other than Giauque, Luo and Spokes, is a citizen of the United States. Giauque is a citizen of France. Luo is a citizen of China. Spokes is a citizen of the United Kingdom. Y The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person. The Shares reported hereby for ZHH LLC are held directly by ZHH LLC. The Shares reported hereby for the Farallon Funds are held directly by the Farallon Funds. The Management Company, as the manager of ZHH LLC, may be deemed to be a beneficial owner of such Shares held by ZHH LLC. The Farallon General Partner, as the general partner of each of FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI, and as the sole member of the FCIP V General Partner, may be deemed to be a beneficial owner of such Shares held by the Farallon Funds other than F5MI. The FCIP V General Partner, as the general partner of FCIP V, may be deemed to be a beneficial owner of such Shares held by FCIP V. The F5MI General Partner, as the general partner of F5MI, may be deemed to be a beneficial owner of such Shares held by F5MI. Each of the Farallon Individual Reporting Persons, as a managing member or senior managing member, as the case may be, of the Management Company and the Farallon General Partner, and as a manager or senior manager, as the case may be, of the FCIP V General Partner and the F5MI General Partner, in each case with the power to exercise investment discretion, may be deemed to be a beneficial owner of such Shares held by ZHH LLC and the Farallon Funds. Each of the Management Company, the Farallon General Partner, the FCIP V General Partner, the F5MI General Partner and the Farallon Individual Reporting Persons hereby disclaims any beneficial ownership of any such Shares. The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person. The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person. The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person. The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person. The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person. Y Y N The Reporting Persons are filing this Schedule 13G pursuant to Section 240.13d-1(c). The Reporting Persons neither disclaim nor affirm the existence of a group among them. Each Reporting Person is a beneficial owner only of the securities reported by it on its cover page. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Zone Healthcare Holdings, LLC /s/ Hannah E. Dunn 11/12/2025 Farallon Capital Partners, L.P. /s/ Hannah E. Dunn 11/12/2025 Farallon Capital Institutional Partners, L.P. /s/ Hannah E. Dunn 11/12/2025 Farallon Capital Institutional Partners II, L.P. /s/ Hannah E. Dunn 11/12/2025 Farallon Capital Institutional Partners III, L.P. /s/ Hannah E. Dunn 11/12/2025 Four Crossings Institutional Partners V, L.P. /s/ Hannah E. Dunn 11/12/2025 Farallon Capital Offshore Investors II, L.P. /s/ Hannah E. Dunn 11/12/2025 Farallon Capital (AM) Investors, L.P. /s/ Hannah E. Dunn 11/12/2025 Farallon Capital F5 Master I, L.P. /s/ Hannah E. Dunn 11/12/2025 Farallon Capital Management, L.L.C. /s/ Hannah E. Dunn 11/12/2025 Farallon Partners, L.L.C. /s/ Hannah E. Dunn 11/12/2025 Farallon F5 (GP), L.L.C. /s/ Hannah E. Dunn 11/12/2025 Farallon Institutional (GP) V, L.L.C. /s/ Hannah E. Dunn 11/12/2025 Dapice Joshua J. /s/ Hannah E. Dunn 11/12/2025 Dreyfuss, Philip D. /s/ Hannah E. Dunn 11/12/2025 Dunn Hannah E. /s/ Hannah E. Dunn 11/12/2025 Fried, Richard B /s/ Hannah E. Dunn 11/12/2025 Gehani, Varun N. /s/ Hannah E. Dunn 11/12/2025 Giauque, Nicolas /s/ Hannah E. Dunn 11/12/2025 Kim, David T. /s/ Hannah E. Dunn 11/12/2025 Linn, Michael G. /s/ Hannah E. Dunn 11/12/2025 Luo Patrick (Cheng) /s/ Hannah E. Dunn 11/12/2025 Patel, Rajiv A. /s/ Hannah E. Dunn 11/12/2025 Roberts, Jr., Thomas G. /s/ Hannah E. Dunn 11/12/2025 Saito Edric C. /s/ Hannah E. Dunn 11/12/2025 Seybold, William /s/ Hannah E. Dunn 11/12/2025 Short Daniel S. /s/ Hannah E. Dunn 11/12/2025 Spokes, Andrew J. M. /s/ Hannah E. Dunn 11/12/2025 Warren, John R. /s/ Hannah E. Dunn 11/12/2025 Wehrly, Mark C. /s/ Hannah E. Dunn 11/12/2025